+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glutamate Receptor"

Spinal Cord Injury - Pipeline Insight, 2021 - Product Thumbnail Image

Spinal Cord Injury - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • 80 pages
From
Glutamate Receptor Antagonists - Pipeline Insight, 2021 - Product Thumbnail Image

Glutamate Receptor Antagonists - Pipeline Insight, 2021

  • Clinical Trials
  • June 2021
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • June 2021
  • 844 Pages
From
CNS Therapeutics - Global Market Trajectory & Analytics - Product Thumbnail Image

CNS Therapeutics - Global Market Trajectory & Analytics

  • Report
  • May 2021
  • 978 pages
From
Amyotrophic Lateral Sclerosis Market Insight, Epidemiology and Market Forecast - 2030 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Market Insight, Epidemiology and Market Forecast - 2030

  • Report
  • March 2021
  • 200 pages
From
Refractory Status Epilepticus - Pipeline Insight, 2021 - Product Thumbnail Image

Refractory Status Epilepticus - Pipeline Insight, 2021

  • Clinical Trials
  • February 2021
  • 60 pages
From
Market Spotlight: Huntington's Disease - Product Thumbnail Image

Market Spotlight: Huntington's Disease

  • Report
  • January 2021
  • 32 Pages
Metabotropic Glutamate Receptor 2 - Pipeline Review, H2 2020 - Product Thumbnail Image

Metabotropic Glutamate Receptor 2 - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 58 pages
From
Metabotropic Glutamate Receptor 5 - Pipeline Review, H2 2020 - Product Thumbnail Image

Metabotropic Glutamate Receptor 5 - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 77 pages
From
Metabotropic Glutamate Receptor 3 - Pipeline Review, H2 2020 - Product Thumbnail Image

Metabotropic Glutamate Receptor 3 - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 40 pages
From
Lennox Gastaut Syndrome - Market Insight, Epidemiology and Market Forecast - 2030 - Product Thumbnail Image

Lennox Gastaut Syndrome - Market Insight, Epidemiology and Market Forecast - 2030

  • Report
  • October 2020
  • 181 pages
From
West Syndrome - Market Insights, Epidemiology and Forecast to 2030 - Product Thumbnail Image

West Syndrome - Market Insights, Epidemiology and Forecast to 2030

  • Drug Pipelines
  • September 2020
  • 131 pages
From
Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2020 - Product Thumbnail Image

Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2020

  • Clinical Trials
  • July 2020
  • 60 pages
From
Ionotropic Glutamate Receptor Antagonist - Pipeline Insight, 2020 - Product Thumbnail Image

Ionotropic Glutamate Receptor Antagonist - Pipeline Insight, 2020

  • Clinical Trials
  • July 2020
  • 120 pages
From
2020 Autism spectrum disorders (ASD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs - Product Thumbnail Image

2020 Autism spectrum disorders (ASD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

  • Report
  • February 2020
  • 127 pages
From
Glutamate Receptor Ionotropic NMDA 2B - Pipeline Review, H2 2019 - Product Thumbnail Image

Glutamate Receptor Ionotropic NMDA 2B - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 54 pages
From
Parkinson's Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects - Product Thumbnail Image

Parkinson's Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects

  • Report
  • May 2019
  • 84 pages
From
Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019 - Product Thumbnail Image

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019

  • Drug Pipelines
  • April 2019
  • 50 pages
From
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019 - Product Thumbnail Image

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019

  • Drug Pipelines
  • March 2019
  • 44 pages
From
Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2018 - Product Thumbnail Image

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2018

  • Drug Pipelines
  • August 2018
  • 78 pages
From
Loading Indicator
adroll